2021 WHO Classification of Lung Cancer: A Globally Applicable and Molecular Biomarker-Relevant Classification

We thank Many Javey and Stephanie Yaung for their letter on this important subject. 1 Javey M, Yaung SY. Incorporating genetic biomarkers in WHO classification of lung cancer. J Thorac Oncol. 2022;17:e79-e80. Google Scholar Incorporating Genetic Biomarkers in WHO Classification of Lung CancerJournal of Thoracic OncologyVol. 17Issue 9PreviewNicholson et al.1 recently published a concise review on the 2021 WHO Classification of Thoracic Tumours,2 focusing on the chapter on lung tumors. The authors summarize updates since 2015, highlighting the greater emphasis throughout the book on advances in molecular pathology and clinical impact of previous updates. Nevertheless, the nomenclature for disease ontologies in the 2021 WHO Classification of lung tumors still lacks genetic biomarkers, which are part of the disease ontologies in the classification of other tumors. Full-Text PDF